MAM
BHVN

Martingale Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Martingale Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,763
Closed -$657K – 902
2021
Q4 		$657K Sell
4,763
-2,901
-38% -$400K 0.01% 581
2021
Q3 		$1.07M Buy
7,664
+3,656
+91% +$508K 0.01% 494
2021
Q2 		$390K Buy
+4,008
New +$390K ﹤0.01% 666